Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Clinical trial NCT02057718 · COMPLETED
Trial details
- NCT number
- NCT02057718
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2020-05-08
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.